Karuna Pharmaceuticals

Schizophrenia is a devastating illness for both patients and their families. Karuna’s mission is to develop first-in-class, novel mechanism-of-action agents that will dramatically improve the lives of people living with schizophrenia. Karuna’s lead program is a clinical stage compound with human proof of concept.